Related Experiment Video
Updated: Jan 30, 2026

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
Hematologic malignancies and Li-Fraumeni syndrome
Mahesh Swaminathan1, Sarah A Bannon2, Mark Routbort3
1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA.
Li-Fraumeni syndrome (LFS) increases cancer risk due to TP53 gene mutations. This study reviews LFS-associated hematologic malignancies in adults, highlighting diagnostic awareness and patient outcomes.
Area of Science:
- Oncology
- Genetics
- Hematology
Background:
- Li-Fraumeni syndrome (LFS) is an inherited disorder characterized by a high predisposition to various cancers.
- Germline mutations in the tumor suppressor gene TP53 are the underlying cause of LFS.
- While acute lymphoblastic leukemia is commonly associated with LFS, myeloid malignancies are also observed, particularly therapy-related ones.
Purpose of the Study:
- To review the clinicopathologic features of hematologic malignancies in adult patients with Li-Fraumeni syndrome.
- To enhance awareness of LFS for timely diagnosis in patients and their families.
- To share clinical experience and patient outcomes in this challenging population.
Main Methods:
- Retrospective review of seven adult patients diagnosed with LFS and hematologic malignancies.
- Evaluation of clinicopathologic characteristics, including cytogenetics and molecular analyses.
- Data collected from the Hereditary Hematologic Malignancy Clinic (HHMC) at MD Anderson Cancer Center.
Main Results:
- Detailed characterization of hematologic malignancies in adult LFS patients.
- Identification of specific cytogenetic and molecular findings in this cohort.
- Insights into the clinical course and treatment responses.
Conclusions:
- Li-Fraumeni syndrome necessitates a high index of suspicion for hematologic malignancies, including myeloid types.
- Comprehensive diagnostic evaluation, including genetic testing, is crucial for LFS patients with blood cancers.
- Understanding LFS-associated hematologic malignancies aids in managing this high-risk patient group.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Acute Coronary Syndrome I: Introduction
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Restless Leg Syndrome and Night Terrors
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
Acute Coronary Syndrome V: Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management

